Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

EGFR Antibody (C225 (Cetuximab)) - Azide and BSA Free, Novus Biologicals™
SDP

Human Monoclonal Antibody

Supplier:  Novus Biologicals NBP275903SS

Catalog No. NBP275903SS


Only null left
Add to Cart

Description

Description

EGFR Monoclonal specifically detects EGFR in Human samples. It is validated for Flow Cytometry, ELISA, Immunohistochemistry, Block/Neutralize.
Specifications

Specifications

EGFR
Monoclonal
Unconjugated
PBS with 0.02% Proclin 300
EGFR
The epidermal growth factor receptor is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands.
0.025 mg
Primary
Recognises human EGFR.
Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
IgG1 κ
Blocking Assay, ELISA, Immunohistochemistry
C225 (Cetuximab)
Flow Cytometry, ELISA, Immunohistochemistry, Block/Neutralize
avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, biosimilar, biosimilars, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, epidermal growth factor receptor, epidermal growth factor receptor
Human
Protein A purified
Cancer, Cell Biology, Cell Cycle and Replication, Cellular Markers, Cellular Signaling, Growth and Development, Hypoxia, Phospho Specific, Signal Transduction, Tumor Suppressors, Tyrosine Kinases
1956.0
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.